The promise of next-generation flow cytometry platforms including mass cytometry (CyTOF) and mass spectrometry-based digital imaging is substantial. With widespread use in immunophenotyping, analysis of hematopoietic neoplasias, diagnosis of primary immunodeficiencies, and for antibody screening and crossmatching, among other applications, flow cytometry is expected to continue to expand its clinical utility and utilization in clinical laboratories.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.